SEOUL — South Korea has licensed the usage of Novavax Inc’s COVID-19 vaccine, the meals and drug security ministry stated on Wednesday.
South Korean vaccine developer SK Bioscience Co Ltd stated it is going to produce the Novavax vaccine.
The 2-dose, protein-based vaccine has secured authorizations from European Union regulators and the World Well being Group.
It has been licensed in India, Indonesia and the Philippines, the place Novavax’s companion, Serum Institute of India, will provide it.
Novavax is awaiting approval in Japan, the place its vaccine could be manufactured and distributed by Takeda Pharmaceutical.
South Korea has already licensed vaccines made by AstraZeneca Inc, Moderna Inc, Pfizer and Johnson & Johnson’s Janssen.
Subscribe to our each day e-newsletter
Subscribe to INQUIRER PLUS to get entry to The Philippine Every day Inquirer & different 70+ titles, share as much as 5 devices, take heed to the information, obtain as early as 4am & share articles on social media. Name 896 6000.
For suggestions, complaints, or inquiries, contact us.